Latest News about BNTX
Recent news which mentions BNTX
WHO has not seen any reports of deaths caused by omicron variant, urges people not to panic as delta still dominant
December 03, 2021
From MarketWatch
2 Stocks That Are Down 60% (or More) From Their 52-Week Highs
December 03, 2021
From Motley Fool
Here's What Vaccine CEOs Have to Say About the Omicron Variant
December 03, 2021
From Motley Fool
From Motley Fool
Hotel Stocks: Why MAR, H, HLT, WH, CHH and IHG Are Booking Gains Today
December 02, 2021
From InvestorPlace
Europe To Start Deliveries Of Pfizer/BioNTech COVID-19 Shot For Children One Week Ahead Of Plan: Reuters
December 02, 2021
From Benzinga
The Daily Biotech Pulse: Moderna, Pfizer-BioNTech Ink New Vaccine Deals With UK, GSK-Vir Antibody Show Activity Against Omicron, Chemomab Gets Clearance
December 02, 2021
From Benzinga
Britain Agrees To New Deals For 114M Additional Moderna, Pfizer/BioNTech COVID-19 Vaccine Doses
December 02, 2021
From Benzinga
Cruise Stocks Alert: Why CCL, RCL, NCLH Stocks Are Getting Wrecked Today
December 01, 2021
From InvestorPlace
From MarketWatch
Why Carnival Stock Investors Have No Worries Today
December 01, 2021
From Motley Fool
U.S. to tighten testing requirements for travelers in light of omicron variant, and analysts expected limited authorization of Merck antiviral
December 01, 2021
From MarketWatch
3 Reasons Pfizer Stock Will Crush the Broader Market in 2022
December 01, 2021
From Motley Fool
Sanofi Adds Acne Vaccine Candidate Via Origimm Biotechnology Acquisition
December 01, 2021
From Benzinga
Have the Markets Overreacted to Omicron?
November 30, 2021
From InvestorPlace
Why Novavax and Pfizer Are Trouncing the Market Today
November 30, 2021
From Motley Fool
From MarketWatch
Omicron variant unlikely to cause severe illness in vaccinated people, BioNTech founder says
November 30, 2021
From MarketWatch
From InvestorPlace
Is This Leading COVID Stock a Buy Right Now?
November 30, 2021
From Motley Fool
FDA May Authorize Pfizer-BioNTech COVID-19 Booster Shots For Age 16-17 Next Week: WSJ
November 30, 2021
From Benzinga
Ocugen Stock Very Well May Have Bottomed Out Here
November 30, 2021
From InvestorPlace
Stock futures tumble anew as Moderna CEO predicts existing vaccines will be less effective against omicron variant
November 30, 2021
From MarketWatch
FDA may OK COVID boosters for 16- and 17-year-olds as soon as next week
November 29, 2021
From MarketWatch
Merriam-Webster Names 'Vaccine' As 2021 Word Of The Year
November 29, 2021
From Benzinga
Carnival Will Survive the Latest Covid-19 Variant Omicron
November 29, 2021
From InvestorPlace
5 Vaccine Stocks to Watch as New Covid-19 Variant Strikes the Market
November 29, 2021
From InvestorPlace
NVAX Stock Is on Watch as Novavax Joins the Omicron Variant Battle
November 29, 2021
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.